Diligence memo · auto-generated · as of July 2, 2026
Convalo Health International, Corp.
Convalo Health International, Corp. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Convalo Health International, Corp. operates in Healthtech, based in LOS ANGELES.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Convalo Health International, Corp. has raised $1.0M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $466K on 2014-02-18.
Most recent recorded round closed around 2016-10-20.
Valuation (modeled)modeled
Provath models Convalo Health International, Corp. at approximately $7.8M (range $444K–$42M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.06× the median modeled value of Series A Healthtech companies in 2016–2018 (103 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 9.7 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.6× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 29% of Healthtech peers (2138 compared).
Modeled value ranks above 29% of those peers.
Closest niche peers: Prenexus Health, LLC, HealthMyne, Inc., Companion Medical, Inc., Health at Scale Corp, Motus GI Medical Technologies, Ltd..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.